LEADER 04519nam  22008655  450 
001 9910799245703321
005 20240227191132.0
010   $a3-031-44528-7
024 7 $a10.1007/978-3-031-44528-6
035   $a(CKB)29526927300041
035   $a(DE-He213)978-3-031-44528-6
035   $a(MiAaPQ)EBC31132611
035   $a(Au-PeEL)EBL31132611
035   $a(EXLCZ)9929526927300041
100   $a20231130d2023      u|             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHepatobiliary Cancers: An Interdisciplinary Approach$b[electronic resource] /$fedited by Nima Rezaei
205   $a1st ed. 2023.
210  1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2023.
215   $a1 online resource (XI, 365 p. 22 illus., 21 illus. in color.)
225 1 $aInterdisciplinary Cancer Research,$x2731-457X ;$v3
311 08$a9783031445279 
327   $aInterdisciplinary Approach in Hepatobiliary Cancers -- Liver Cancer: Interdisciplinary Approach -- The Immune System in Liver Cancer: From Beginning to Progression -- The Tumor Microenvironment in Hepatocellular Carcinoma -- Metabolic Alterations of Hepatocellular Cancer Stem Cells -- ?he Role of Senescence in NASH-related HCC -- Regulators of Genetic Risk for the Progression of Non-alcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Reconstruction of Transcriptional Network and Signature-Based Metabolic Profiling -- Tumor Microenvironment and Immunotherapy in Advanced Biliary Tract Cancers -- Fibrosis and Immunotherapy in Hepatocellular Carcinoma -- Liver Cancer and the Curative Potential of Nanomedicine -- Locoregional Therapies for Hepatocellular Carcinoma -- Drug Resistance in Hepatocellular Carcinoma -- Liver Stereotactic Body Radiotherapy.
330   $aHepatobiliary cancers, including hepatocellular carcinoma and biliary tract cancers, have high rate of mortality and low survival rate. The third volume of the ?Interdisciplinary Cancer Research? series, entitled ?Hepatobiliary Cancers: An Interdisciplinary Approach? publishes comprehensive volumes on mechanisms of hepatobiliary cancers and therapeutic modalities and presents the most updated and peer-reviewed chapters on hepatobiliary cancers. This interdisciplinary series is of special value to researchers working on cell biology, immunology, biochemistry, genetics, and practitioners working on oncology and gastroenterology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for researchers, oncologists, and gastroenterologists who wish to extend their knowledge on hepatobiliary cancers.
410  0$aInterdisciplinary Cancer Research,$x2731-457X ;$v3
606   $aCancer
606   $aCancer$xTreatment
606   $aTumors$xImmunological aspects
606   $aImmunotherapy
606   $aCancer$xGenetic aspects
606   $aStem cells
606   $aStem Cells
606   $aDigestive System Diseases
606   $aCarcinoma, Hepatocellular$xtherapy
606   $aLiver Neoplasms$xtherapy
606   $aImmunotherapy
606   $aBiliary Tract Neoplasms$xtherapy
606   $aCancer Biology
606   $aCancer Therapy
606   $aTumour Immunology
606   $aImmunotherapy
606   $aCancer Genetics and Genomics
606   $aCancer Stem Cells
615  0$aCancer.
615  0$aCancer$xTreatment.
615  0$aTumors$xImmunological aspects.
615  0$aImmunotherapy.
615  0$aCancer$xGenetic aspects.
615  0$aStem cells.
615  2$aStem Cells.
615  2$aDigestive System Diseases.
615  2$aCarcinoma, Hepatocellular$xtherapy.
615  2$aLiver Neoplasms$xtherapy
615  2$aImmunotherapy.
615  2$aBiliary Tract Neoplasms$xtherapy.
615 14$aCancer Biology.
615 24$aCancer Therapy.
615 24$aTumour Immunology.
615 24$aImmunotherapy.
615 24$aCancer Genetics and Genomics.
615 24$aCancer Stem Cells.
676   $a571.978
676   $a616.994
702   $aRezaei$b Nima$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910799245703321
996   $aHepatobiliary Cancers: An Interdisciplinary Approach$93877390
997   $aUNINA